Formula: | C18H14N4O2 |
Molecular Weight: | 318.34 |
Rotatable Bond Donors: | 3 |
clogP: | 3.70 |
Topological Polar Surface Area: | 97.05 |
Lipinski's RO5: | MW: 318.34 HBA: 6 HBD: 4 RB: 3 LogP: 3.70 |
Rule of Three: | MW: 318.34 HBA: 6 HBD: 4 RB: 3 LogP: 3.70 |
|
DB |
---|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC11757505 | 1.0 | ZINC11757505 RDKit 3D 24 27 0 0 0 0 0 0 0 0999 V2000 -7.0374 0.8355 -0.1077 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.8748 0.6158 0.6511 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.9425 0.5634 2.0422 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7895 0.3457 2.7913 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5646 0.1798 2.1483 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4768 0.2291 0.7547 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1900 0.0542 0.0942 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.9288 -0.1707 0.6214 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0014 -0.2689 -0.4446 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3686 -0.4755 -0.5881 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1568 -0.6977 0.5327 O 0 0 0 0 0 0 0 0 0 0 0 0 3.4941 -0.4073 0.4167 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3972 -1.3492 0.9080 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7643 -1.0785 0.8831 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2263 0.1401 0.3916 C 0 0 0 0 0 0 0 0 0 0 0 0 5.3102 1.0794 -0.0666 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7612 2.2770 -0.5345 O 0 0 0 0 0 0 0 0 0 0 0 0 3.9450 0.8270 -0.0505 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9113 -0.5386 -1.8272 N 0 0 0 0 0 0 0 0 0 0 0 0 1.0933 -0.3574 -2.8799 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2318 -0.1313 -2.8663 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.7203 -0.1040 -1.6158 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.0275 0.0904 -1.2704 N 0 0 0 0 0 0 0 0 0 0 0 0 -4.6432 0.4485 0.0162 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 2 0 3 4 1 0 4 5 2 0 5 6 1 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 12 13 2 0 13 14 1 0 14 15 2 0 15 16 1 0 16 17 1 0 16 18 2 0 10 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 22 23 1 0 6 24 2 0 24 2 1 0 23 7 1 0 22 9 1 0 18 12 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |